UK Pharma Series C+ Funding Rounds 2026
Every UK Series C+ Pharma funding round filed in 2026, sourced direct from Companies House filings. Updated weekly.
UK Pharma Series C+ Funding Rounds 2026
| Company | Raised | Round | Date |
|---|---|---|---|
| Centessa Pharmaceuticals | £574.8M | Series C Plus | 2026/03/13 |
| Solstice Oncology Uk | £22.1M | Series C Plus | 2026/03/11 |
| Myricx Pharma | £39.6M | Series C Plus | 2026/03/03 |
| Celadon Pharmaceuticals | £30k | Series C Plus | 2026/02/17 |
| Cristae Therapeutics | £333k | Series C Plus | 2026/01/21 |
More Pharma funding
- UK Pharma Funding Rounds 202679
- London Pharma Funding Rounds 202619
- UK Pharma Seed Funding Rounds 202613
- Altrincham Pharma Funding Rounds 20268
- Cambridge Pharma Funding Rounds 20267
- UK Pharma Series A Funding Rounds 20266
- London Pharma Funding Rounds32
- UK Pharma Series A Funding Rounds29
- UK Pharma Seed Funding Rounds24
- Cambridge Pharma Funding Rounds13
- UK Pharma Series B Funding Rounds11
- Altrincham Pharma Funding Rounds11
- UK Pharma Series C+ Funding Rounds6
- Oxford Pharma Funding Rounds6